Company profile for Apex Labs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

APEX’s clinical development program is focused on Veterans – a population disproportionately affected by mental health conditions. The Company’s lead clinical candidate is a low-dose synthetic psilocybin product for the treatment of Post-Traumatic Stress Disorder (PTSD) and treatment resistant depression. APEX’s strategy is to develop drug products including Active Pharmaceutical Ingredients (API) produced by chemic...
APEX’s clinical development program is focused on Veterans – a population disproportionately affected by mental health conditions. The Company’s lead clinical candidate is a low-dose synthetic psilocybin product for the treatment of Post-Traumatic Stress Disorder (PTSD) and treatment resistant depression. APEX’s strategy is to develop drug products including Active Pharmaceutical Ingredients (API) produced by chemical synthesis, and also drug products with botanically sourced API, differentiating APEX by diversifying APEX’s options for development and commercialization of drug products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
1050–1040 West Georgia Street, Vancouver, BC, V6B 4H1
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

SCOPE Summit

SCOPE Summit

Not Confirmed

envelop Contact Supplier

SCOPE Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/apex-labs-files-ind-with-fda-for-microdose-psilocybin-study-302178089.html

PR NEWSWIRE
20 Jun 2024

https://www.prnewswire.com/news-releases/apex-labs-files-for-us-patent-protecting-psychedelic-drug-delivery-system-302083085.html

PR NEWSWIRE
07 Mar 2024

https://www.prnewswire.com/news-releases/apex-labs-granted-dealers-licence-by-health-canada-302061256.html

PR NEWSWIRE
14 Feb 2024

https://www.prnewswire.com/news-releases/canadian-veteran-dosed-with-first-cycle-of-apex-90-macrodose-psilocybin-in-apex-labs-early-access-program-301974977.html

PR NEWSWIRE
02 Nov 2023

https://www.prnewswire.com/news-releases/apex-labs-announces-the-appointment-of-chief-medical-officer--chief-commercial-officer-301898017.html

PR NEWSWIRE
10 Aug 2023

https://www.prnewswire.com/news-releases/apex-labs-receives-approval-for-us-based-secondary-gmp-psilocybin-supplier-by-health-canada-301847331.html

PR NEWSWIRE
09 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty